A Nuclear Receptor Atlas: macrophage activation.
暂无分享,去创建一个
R. Evans | G. Barish | M. Downes | W. Alaynick | R. Yu | C. Ocampo | A. Bookout | D. Mangelsdorf | Corinne B Ocampo | R. Evans
[1] F. M. Berger. The effect of endotoxin on resistance to infection and disease. , 1967, Advances in pharmacology.
[2] R. Macdermott,et al. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. , 1980, Journal of immunology.
[3] S. Manolagas,et al. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. , 1983, Science.
[4] R. Mertelsmann,et al. Activation of human macrophages. Comparison of other cytokines with interferon-gamma , 1984, Journal of Experimental Medicine.
[5] J. Mcghee,et al. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice , 1984, Infection and immunity.
[6] D. Housman,et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. , 1987, Science.
[7] J. Frelinger,et al. Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection , 1988, Infection and immunity.
[8] J. Funder,et al. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. , 1988, Science.
[9] M. Karin,et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.
[10] S. Kliewer,et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor , 1990, Cell.
[11] Stephan Gebel,et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.
[12] Leonard,et al. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. , 1990, The American journal of pathology.
[13] R. Maier,et al. Interferon γ increases sensitivity to endotoxin , 1991 .
[14] H. Koeffler,et al. 1,25-Dihydroxyvitamin D3 receptor RNA: expression in hematopoietic cells , 1991 .
[15] J. Vilček,et al. Mice That Lack the Interferon- 7 Receptor Have Profoundly Altered Responses to Infection with Bacillus Calmette-Gu6rin and Subsequent Ch-ilenge with Lipopolysaccharide By Ryutaro Kamijo,* Junming l.e,* Deborah Shapiro,* , 1993 .
[16] S. Snyder,et al. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. , 1993, The Journal of biological chemistry.
[17] K. Umesono,et al. Unique response pathways are established by allosteric interactions among nuclear hormone receptors , 1995, Cell.
[18] Joseph A. DiDonato,et al. Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.
[19] A. Baldwin,et al. Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.
[20] The immune response against Francisella tularensis live vaccine strain in Lpsn and Lpsd mice , 1996 .
[21] S. Russell,et al. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages , 1996, Journal of leukocyte biology.
[22] D. Charnock-Jones,et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. , 1996, The Journal of clinical investigation.
[23] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] Christopher K. Glass,et al. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.
[25] H. DeLuca,et al. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. , 1998, The Journal of nutrition.
[26] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[27] R. Hannon,et al. Endogenous monocyte chemoattractant protein‐1 recruits monocytes in the zymosan peritonitis model , 1998, Journal of leukocyte biology.
[28] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[29] B. Rollins,et al. Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.
[30] P. Libby,et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.
[31] J. Quach,et al. Interleukin-17-induced Gene Expression in Articular Chondrocytes Is Associated with Activation of Mitogen-activated Protein Kinases and NF-κB* , 1998, The Journal of Biological Chemistry.
[32] B. Seed,et al. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines , 1998, Nature.
[33] C. Yang,et al. Two organochlorine pesticides, toxaphene and chlordane, are antagonists for estrogen-related receptor alpha-1 orphan receptor. , 1999, Cancer research.
[34] T. Hosono,et al. An isoform of Nurr1 functions as a negative inhibitor of the NGFI-B family signaling. , 1999, Biochimica et biophysica acta.
[35] K. Umesono,et al. A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.
[36] Ming Li,et al. A Critical Role for the RelA Subunit of Nuclear Factor κB in Regulation of Multiple Immune-response Genes and in Fas-induced Cell Death , 1999, The Journal of experimental medicine.
[37] M. Cantorna,et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. , 2000, The Journal of nutrition.
[38] J. Steer,et al. Glucocorticoids Suppress Tumor Necrosis Factor-α Expression by Human Monocytic THP-1 Cells by Suppressing Transactivation through Adjacent NF-κB and c-Jun-Activating Transcription Factor-2 Binding Sites in the Promoter* , 2000, The Journal of Biological Chemistry.
[39] P. Edwards,et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Mattson,et al. Antiinflammatory effects of estrogen on microglial activation. , 2000, Endocrinology.
[41] W. Wahli,et al. Critical roles of PPARβ/δ in keratinocyte response to inflammation , 2001 .
[42] A. Sala,et al. Estrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia , 2001, The Journal of Neuroscience.
[43] R. Evans,et al. Nuclear receptors and lipid physiology: opening the X-files. , 2001, Science.
[44] Chilakamarti V. Ramana,et al. Biologic consequences of Stat1-independent IFN signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Rossant,et al. Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR beta. , 2001, Genes & development.
[46] R. Evans,et al. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.
[47] S. Saccani,et al. Two Waves of Nuclear Factor κb Recruitment to Target Promoters , 2001, The Journal of experimental medicine.
[48] Ricardo Rocha,et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. , 2002, American journal of physiology. Heart and circulatory physiology.
[49] T. Meehan,et al. The vitamin D receptor is necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice ☆ , 2002 .
[50] J. Aubin,et al. Estrogen receptor-related receptor alpha impinges on the estrogen axis in bone: potential function in osteoporosis. , 2002, Endocrinology.
[51] Chilakamarti V. Ramana,et al. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling , 2002 .
[52] T. Meehan,et al. CD8+ T cells are not necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Delyani,et al. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. , 2002, Endocrinology.
[54] P. Chambon,et al. Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[55] K. S. A. Wansa,et al. The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation by the Purine Anti-metabolite 6-Mercaptopurine* , 2003, Journal of Biological Chemistry.
[56] B. Beutler,et al. Innate immune sensing and its roots: the story of endotoxin , 2003, Nature Reviews Immunology.
[57] Dennis B. Lubahn,et al. Estrogen Receptor α Mediates Estrogen’s Immune Protection in Autoimmune Disease , 2003, The Journal of Immunology.
[58] T. Mak,et al. Nur77 as a survival factor in tumor necrosis factor signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[59] Jiahuai Han,et al. Orphan Nuclear Receptor Nur77 Is Involved in Caspase-independent Macrophage Cell Death , 2003, The Journal of experimental medicine.
[60] Anastasia Kralli,et al. The Transcriptional Coactivator PGC-1 Regulates the Expression and Activity of the Orphan Nuclear Receptor Estrogen-Related Receptor α (ERRα)* , 2003, The Journal of Biological Chemistry.
[61] Xiaohong Liu,et al. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors , 2003, Nature.
[62] M. Embleton. The Macrophage (2nd Edn) , 2003, British Journal of Cancer.
[63] William A. Boisvert,et al. Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ , 2003, Science.
[64] B. Komm,et al. Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease , 2003 .
[65] C. Glass,et al. PPARγ and PPARδ negatively regulate specific subsets of lipopolysaccharide and IFN-γ target genes in macrophages , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[66] I. Zachary,et al. Vascular Endothelial Growth Factor–Regulated Gene Expression in Endothelial Cells: KDR-Mediated Induction of Egr3 and the Related Nuclear Receptors Nur77, Nurr1, and Nor1 , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[67] Xiaohui S. Xie,et al. Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle , 2004 .
[68] D. Lubahn,et al. Estrogen receptor‐α deficiency promotes increased TNF‐α secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro , 2004 .
[69] D. Bredesen,et al. Alternative, Nonapoptotic Programmed Cell Death , 2004, Journal of Biological Chemistry.
[70] A. August,et al. Vitamin D Receptor-Deficient Mice Fail to Develop Experimental Allergic Asthma1 , 2004, The Journal of Immunology.
[71] Peter Tontonoz,et al. LXR-Dependent Gene Expression Is Important for Macrophage Survival and the Innate Immune Response , 2004, Cell.
[72] R. Coleman,et al. Aldosterone Administration to Mice Stimulates Macrophage NADPH Oxidase and Increases Atherosclerosis Development: A Possible Role for Angiotensin-Converting Enzyme and the Receptors or Angiotensin II and Aldosterone , 2004, Circulation.
[73] I. Lindley,et al. Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB. , 2004, Nucleic acids research.
[74] M. Young,et al. Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone/salt-treated rats. , 2004, Endocrinology.
[75] John Calvin Reed,et al. Conversion of Bcl-2 from Protector to Killer by Interaction with Nuclear Orphan Receptor Nur77/TR3 , 2004, Cell.
[76] K. Schroder,et al. Interferon- : an overview of signals, mechanisms and functions , 2004 .